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Alzheimer’s disease
Protein misfoldingSoluble Amyloid-beta (Ab) oligomers are a source of cytotoxicity in Alzheimer’s disease (AD). The
toxicity of Ab oligomers may arise from their ability to interact with and disrupt cellular membranes
mediated by GM1 ganglioside receptors within these membranes. Therefore, inhibition of Ab–mem-
brane interactions could provide a means of preventing the toxicity associated with Ab. Here, using
Surface Plasmon field-enhanced Fluorescence Spectroscopy, we determine that the lanthanide,
Europium III chloride (Eu3+), strongly binds to GM1 ganglioside-containing membranes and pre-
vents the interaction with Ab42 leading to a loss of the peptides ability to cause membrane perme-
ation. Here we discuss the molecular mechanism by which Eu3+ inhibits Ab42-membrane
interactions and this may lead to protection of membrane integrity against Ab42 induced toxicity.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical
Societies. This is an open access article under the CC BY license (http://creativecommons.org/licenses/
by/4.0/).1. Introduction membranes. The propensity for peptides to form amyloid fibers isAlzheimer’s disease (AD) is the most common form of dementia
worldwide, with a global cost of over $600 billion in 2012 [1]. The
pathological hallmarks of AD include the loss of neurons, the accu-
mulation of neuritic plaques composed of extracellular, fibrillar
Amyloid-beta peptide (Ab), and the deposition of intraneuronal
neurofibrillary tangles composed of tau [2]. Ab1–42 (Ab42) is the
predominant variant deposited in AD brains.
The proteolytic cleavage of the integral membrane protein,
Amyloid Precursor Protein (APP), at the N- and C-termini by b- and
c-secretase respectively, results in the release of Ab [3]. This release
of Ab from its transmembrane location means that the peptide
retains an ability to interact with and/or insert into biologicalpromoted by the b-strand conformation forming stable networks
of hydrogen bonds that result in characteristic cross-b structures
[4]. The hydropathic properties and charges on specific amino acids
in the polypeptide chain also influence the peptide’s ability to inter-
act with surfaces such as membranes [5–7]. Therefore, subtle alter-
ations in surface andmembraneproperties could dramatically affect
both Ab–Ab and Ab–surface interactions.
Biological membranes are composed of complex mixtures of
phospholipids, proteins, and membrane receptors. Gangliosides
are a type of glycosphingolipid found in the outer leaflet of eukary-
otic membranes that are composed of a hydrophobic, membrane-
embedded ceramide and a hydrophilic sialic acid moiety [8]. Gan-
gliosides serve a variety of functions such as cell type-specific
markers, differentiation and developmental markers, receptors,
and as mediators of cell adhesion [9]. Expression of the GM1 gan-
glioside in the eukaryotic membrane is typically around 2% (w/w)
[10], but can vary between 0.5% and 13% (w/w) depending on cell
type and cell cycle stage [11–14]. The GM1within lipid membranes
has previously been shown to significantly affect the affinity of
Ab42 for the membrane. We have previously shown that Ab oligo-
mers possess high affinity and high avidity to GM1-containing
membranes [15]. In our previous study, we showed that Ab
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the peptide causes the formation of well-defined holes and defects
[15]. GM1 has been shown to significantly affect the assembly state
and oligomerization of Ab, and it was recently reported that
increasing concentrations of GM1 induces a greater proportion of
b-sheet structure within Ab [16,17]. GM1-bound Ab was proposed
to act as a seed in the fibrillization of the peptide, and fibril exten-
sion occurred via consecutive binding of soluble Ab at the ends of
the growing fibrils [18]. Therefore, GM1 may provide an ideal sur-
face for Ab adsorption via effective hydrophobic and electrostatic
interactions, and blocking of this receptor could significantly affect
both Ab–membrane interactions and Ab-induced permeation.
Europium and other lanthanide complexes have been used to
detect neutral sugars and glycolipids in ovarian cancer diagnostics
[19] because the metal center of the europium cooperatively co-
ordinates to the oligosaccharide and sialic acid moiety of ganglio-
sides [19]. Europium complexes have received much attention as
both therapeutic and diagnostic agents, including as angiogenic
inhibitors [20], in vivo neuroimaging agents [21,22], as therapeutic
agents in the treatment of ischemic heart disease [23], in myocar-
dial infractions [24], and are reviewed in [25]. Williams et al. pre-
viously reported the potential use of europium (Eu3+) as a means of
inhibiting the binding of cholera toxin to tethered large unilamel-
lar vesicles (LUV) [26]. Here, we report the effect of Eu3+ complexed
to GM1-containing membranes on the avidity and affinity of Ab42
binding to membranes in vitro, and the ability of Eu3+-coordinated
membranes to resist Ab-induced membrane permeation. We also
determine the sequence of events that occur during Ab–membrane
binding, permeation and GM1 mediated seeding during Ab fibril
formation.
2. Experimental procedures
2.1. Amyloid peptides
Ab1–42 HFIP (referred to as Ab42), >97% purity was purchased
from rPeptide (Bogart, GA, USA). All peptides were used without
further purification.
2.2. Peptide preparation
Ab42 was prepared as described previously [27]. Briefly,
1 mg mL1 Ab42 was solubilized in 1,1,1,3,3,3-hexafluoro-2-propa
nol (HFIP) (Fluka, Sigma–Aldrich Company Ltd., Dorset, UK), vor-
texed for 60 s and bath sonicated for 60 s. Solvent was removed
using a stream of dry nitrogen and vacuum desiccated for
30 min. Ab42 was re-solubilized at 1 mg mL1 with dimethyl sul-
foxide (DMSO) >99.9% (Sigma–Aldrich Company Ltd., Dorset, UK),
vortexed vigorously for 60 s and sonicated for 60 s. The peptide
was buffer exchanged with 10 mM HEPES, 100 mM NaCl, 1 mM
EDTA, and 0.05 mM NaN3 (all purchased from Sigma–Aldrich Com-
pany Ltd., Dorset, UK), and referred to as HEPES pH7.4, using a
ZebaTM desalt spin column. The eluted peptide was centrifuged in
a 4 C microcentrifuge (Eppendorf UK Ltd., Cambridge, UK) at
16,000g for 30 min and the concentration determined using a
Biophotometer (Eppendorf UK Ltd., Cambridge, UK). This prepara-
tion has been previously characterized and confirmed to contain
predominantly oligomeric Ab42 [27,28]. Freshly prepared Ab42
was used for the experiments immediately, while Ab42 fibers were
prepared by statically incubating oligomeric Ab42 at 21 C for 24 h.
2.3. Europium III chloride and other lanthanide metal ion preparation
Europium III chloride (Eu3+), erbium III chloride, gadolinium III
chloride, lanthanum III chloride, terbium III chloride and ytterbium
III chloride (99.99% anhydrous, Sigma) were diluted to a stockconcentration of 1 mM in HEPES pH 7.4, and then diluted to the
working concentrations (10 and 100 lM).
2.4. Biomimetic membrane constituents
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-dim
yristoyl-sn-glycero-3-phosphoethanolamine (DMPE), 1,2-dim
yristoyl-sn-glycero-3-phospho-(10-rac-glycerol) (DMPG), 1,2-dim
yristoyl-sn-glycero-3-phospho-L-serine (DMPS) and 1-oleoyl-
2-(12-biotinyl(aminododecanoyl))-sn-glycero-3-phosphoethanola
mine (Biotin-PE) were purchased from Avanti Polar Lipid Inc. (Ala-
baster, AL, US). Cholesterol, 95% and Monosialoganglioside GM1
from bovine brain, >95% lyophilized powder were purchased from
Sigma–Aldrich Company Ltd. (Dorset, UK). All materials were used
without further purification. The phospholipid composition was
previously used to study Ab interactions with biomimetic mem-
brane models [15]. This composition was used as it contains rele-
vant phospholipid headgroups and sterols at realistic proportions
to natural, biological membranes found in eukaryotic cells and
ensures a relevant zwitterionic (phosphatidylcholine 50% and
phosphatidylethanolamine 10%) and anionic (phosphatidylserine
2–5% and phosphatidylglycerol 2–5%) lipid ratio found within
cellular membranes [29–31]. Cholesterol typically comprises
around 30% of the eukaryotic phospholipid membrane [32], but
can vary depending of the cell type [33], while GM1 is present at
a molar ratio of around 2% [10].
2.5. Calcein-encapsulated large unilamellar lipid vesicles (LUVs)
Calcein encapsulated at a self-quenching concentration within
the aqueous space of lipid vesicle lumen undergoes fluorescence
dequenching as it diffuses into the external surrounding solution,
resulting in an increase in calcein fluorescence intensity at
520 nm. Calcein-encapsulated LUVs were prepared as described
previously [27]. Briefly, 40 mg mL1 68:30:2 (w/w) DMPC/choles-
terol/GM1 lipid films were rehydrated to 10 mg mL1 with
200 mM calcein in HEPES pH 7.4 (Sigma–Aldrich Company Ltd.,
Dorset, UK), and vortexed vigorously for 30 min. The resulting sus-
pension was passed 19 times through an Avestin extruder fitted
with two stacked 100 nm polycarbonate membranes (GC Technol-
ogy Ltd., Bedford, UK). Non-encapsulated calcein was removed
from the LUVs using a 1 mL sephadex G-50 minicolumn prepara-
tion and spun in a 4 C controlled Mikro 22R centrifuge at 2000
RPM for 3 min to dispel the LUVs into the centrifuge tube. The
eluted LUVs were washed a further two times. The LUVs were
diluted to 1 mg mL1 in HEPES pH 7.4, and stored at 4 C until
use. 100 lM Eu3+ was added to calcein loaded LUVs and mixed
gently at 300 rpm for 30 min to allow complexation.
The encapsulation of calcein was confirmed in the fluorimeter
by determining the release of the self-quenched calcein upon the
addition of 0.5% (v/v) Triton X-100. If the calcein intensity did
not exceed 100% of the starting fluorescence intensity prior to tri-
ton addition, then the LUVs were discarded. Percentage calcein
release was calculated according to:
% Release ¼ ðF  F0Þ  100=ðFmax  F0Þ ð1Þ
where F is the measured fluorescence intensity of calcein at the
specific time, F0 is the initial measured fluorescence intensity at
time = 0 min, Fmax is the maximum fluorescence intensity measured
by the complete lysis of LUVs by the addition of the triton
surfactant.
2.6. Fluorescence Spectroscopy
Fluorescence measurements were carried out on a Cary Eclipse
fluorimeter (Varian Ltd., Oxford, UK). Samples were placed in a
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the calcein fluorescence was monitored at various time points
using an excitation wavelength of 490 nm. Calcein emission was
monitored between 500 and 600 nm, with maximum fluorescence
intensity at around 520 nm at a controlled temperature of 21 C.
Excitation and emission slits were both set to 10 nm, and a scan
rate set to 100 nm/min with 0.833 nm data intervals and an aver-
aging time of 0.55 s. The photomultiplier tube was set to 400 V.
Experiments were carried out in duplicate to confirm trends. Fluo-
rescence intensities at the peak of 520 nm were plotted against
time.
2.7. SPFS tethered large unilamellar vesicles
40 mg mL1 stock solutions of the bilayer constituents were sol-
ubilized in 2:1 (v/v) chloroform/methanol and stored at 20 C
until use. A mixed lipid solution was prepared in a glass vial from
the stock solutions containing (50:13:2:2:30:2:1 w/w) DMPC/DM
PE/DMPG/DMPS/Cholesterol/GM1/Biotin-PE and the solvent was
removed using a stream of dry nitrogen and vacuum desiccated
overnight. The lipid films were rehydrated with 5 lM BODIPY
dye (6-(((4,4-difluoro-5-(2-pyrrolyl)-4-bora-3a,4a-diaza-sinda
cene-3-yl)styryloxy)acetyl) aminohexanoic acid, sulfotetrafluo-
rophenyl ester, sodium salt) (excitation wavelength = 648 nm,
emission wavelength = 660 nm) (Molecular Probes, Invitrogen
Ltd., UK) hydrolyzed to form the carboxylic acid dissolved in HEPES
pH 7.4, and vortexed vigorously for 30 min. BODIPY is not a self-
quenching dye at the concentrations used in these experiments,
therefore is applicable to use with the SPFS system. The resulting
suspension was passed 19 times through an Avestin extruder fitted
with two stacked 100 nm polycarbonate membranes (GC Technol-
ogy Ltd., Bedford, UK). Changes in mass (ng mm2) at the sensor
surface are calculated using:
ðAÞ ¼ DhðDh=rÞ ð2Þ
where (A) is the absorbance in ng mm2, (Dh/r) is the surface con-
centration correlation of 0.1868 and Dh is the shift in resonance
minimum. The fluorescence flux through the permeated mem-
branes (D*) were calculated as previously described [15], and the
KD (Eq. (4)) was calculated using the koff (Eq. 3a) and kon (Eq. 3b) dis-
sociation and association equations, respectively using Origin 7 data
analysis software (OriginLab):
Rt ¼ R0 expkoff t ð3aÞ
dRt
dt
¼ kon½PtRmax  Rtðkon½Pt þ koff Þ ð3bÞ
where
KD ¼ koff =kon ð4Þ
The equilibrium dissociation constant (KD) was determined, and all
changes in reflectivity were normalized. The apparent dye diffusion
coefficient (D*), that is a product of the fluorophore flux through
permeated membranes, is calculated from the linearized change
in fluorescence over time (extrapolated linearized slope of the dye
diffusion rate), and takes into account vesicle membrane internal
volume and membrane area and thickness.
2.8. SPFS bilayer preparation
For SPFS, the procedure for tethering of the LUVs can be found
in detail in Ref. [15]. Briefly, gold-coated SFL6 glass were immersed
in an ethanolic solution of 0.05 mM 11-mercaptoundecanoic-(8-b
iotinoylamido-3,6-dioxaoctyl) amide and 0.95 mM 11-mercapto-
1-undecanol (99%, Sigma) and allowed to self-assemble onto thegold substrates for 16 h. The biotin surface was coupled with strep-
tavidin (500 nM in HEPES pH 7.4). The biotin tagged vesicles were
capture to the streptavidin surface and binding followed by SPR.
Vesicles were tethered for 30 min before rinsing in buffer to
remove no encapsulated fluorophore and non-bound vesicles from
the system. A detailed schematic of the SPFS setup, flow-cell setup
and extensive background to SPFS principles can be found in [34].
A 1 mM stock of europium III chloride in HEPES pH 7.4 was pre-
pared, and then diluted to the working concentration (10–
100 lM) prior to injection into the flow cell and allowed to adsorb
to the GM1-containing LUVs for 30 min prior to rinsing of the flow-
cell with fresh HEPES pH 7.4. Solutions were circulated around the
flow-cell at a rate of 1.8 mL min1 using a peristaltic pump for opti-
mized analyte delivery, while minimizing the mass transport
effects and the shear force on the bilayer vesicles.
2.9. Transmission electron microscopy
A 4 ll droplet of the peptide (80 lM) was adsorbed onto form-
var/carbon coated 400 mesh copper grids (Agar Scientific, Essex,
UK) for 60 s, and blotted dry. 4 ll of 0.22 lm filtered water was
added to the grid and immediately blotted, then negatively stained
with 4 ll of 2% uranyl acetate adsorbed for 60 s and blotted dry.
The grid was allowed to air dry before examination on a Hitachi
7100 microscope (Hitachi, Germany) fitted with a Gatan Ultrascan
1000 CCD camera (Gatan, Abingdon, UK). Aliquots of samples at
the stock concentration were taken at time points for each exper-
iment to monitor fibrillization. Measurements were made using
ImageJ [35].
3. Results
3.1. Solubilized Ab42 forms small, soluble oligomers that assemble to
form fibers
Transmission electron microscopy (TEM) confirmed the oligo-
meric and fibrillar morphology of the Ab42 peptide following dis-
solution and then after 24 h incubation, respectively. A
substantial in depth characterization of both peptide preparation
protocol and Ab–membrane permeation has previously been car-
ried out using calcein release, TEM, circular dichroism, SPFS, and
atomic force microscopy [15,27]. We showed that Ab42 used
immediately after preparation formed small, circular oligomeric
assemblies ranging in size between 1 and 5 nm, [15,27]. Electron
micrographs of 24 h incubated peptide showed larger assemblies
composed of curvilinear oligomers, and small protofibrils ranging
between 15 and 30 nm, and small fibers ranging between 140
and 240 nm in length and 5 nm in width [27]. Moreover, Ab oligo-
mers in the presence of Eu3+ were observed to form fibrils indistin-
guishable from fibrils formed in the absence of Eu3+, therefore, Eu3+
does not adversely affect the morphology of the assembling pep-
tides or alter the aggregation pathway (Supplementary Fig. 1).
3.2. Selection of Eu3+ as inhibitory agent as opposed to other
lanthanide ions
Surface Plasmon field enhanced Fluorescence Spectroscopy
(SPFS) was used to screen potential candidate lanthanide ions for
complexation to GM1-containing membranes. Initially, increasing
concentrations (0–10 lM) of the positive control cholera toxin
(Ctx) were added to the tethered LUVs that had no lanthanide
metal ions coordinated, and the mass adsorption of the control
protein measured (Supplementary Fig. 2). This measurement was
to determine the appropriate concentration of Ctx to add to the lan-
thanide coordinated LUVs for comparison. A concentration depen-
dent increase in Ctx adsorption was observed and when
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10 lM Ctx was used to ensure a like-for-like comparison between
the lanthanide species. Erbium III chloride, europium III chloride,
gadolinium III chloride, lanthanum III chloride, terbium III chloride
or ytterbium III chloride were added to the tethered membrane
vesicles and allowed to complex with the membrane, and the
amount of metal ion adsorption determined (Fig. 1). To test the
abilities of the lanthanide ions to resist peptide-induced perme-
ation, Ctx was injected into the system and the permeation deter-
mined (Fig. 1). The Ctx specifically associates with gangliosides,
therefore this positive control was used to ensure that maximal
permeation of the membranes was observed in order select the
most appropriate lanthanide ion to use in this study.
The addition of the six different lanthanide metal ions resulted
in varying levels of adsorption to the GM1 containing membranes
(Fig. 1). Gadolinium showed the lowest affinity binding to the teth-
ered membranes, followed by ytterbium and erbium. Terbium
showed the third highest amount of metal ion binding to the mem-
branes, followed by lanthanum. The highest amount of metal ion
binding was observed with europium ions (Fig. 1). ANOVA statisti-
cal analysis shows a significant difference between the groups of
the metal ions in the amount of metal ion binding to the GM1-
containing membranes (P < 0.05).
The addition of the 10 lM Ctx to lanthanide-complexed mem-
branes resulted in a significant reduction in permeation of the
membranes compared to Ctx alone (Fig. 1). All lanthanides tested
using the positive control Ctx toxin resulted in similar abilities to
reduce membrane permeation. ANOVA statistical shows no signif-
icant difference between the lanthanides ability to cause reduced
permeation (P > 0.05). However, there is a statistical significance
between the lanthanides ability to reduce permeation compared
to when no lanthanides are present (P < 0.05), whereby on average
the lanthanide complexed LUVs showed a 40% reduction in perme-
ation compared to when no lanthanides were present. We selected
europium ions in this study because it showed the highest mass
adsorption to the membranes, while similarly causing a reduction
in the ability for the positive control to cause membrane perme-
ation. Selection of europium trivalent ions appeared as the most
suitable candidate to ensure the greatest binding to the biomimetic
membranes for the subsequent studies using the Ab peptide toFig. 1. Mass adsorption of lanthanide ions to GM1-containing LUVs and total proportion o
to GM1-containing LUVs, showing a higher mass adsorption of europium trivalent met
10 lM positive control cholera toxin (Ctx) show that all lanthanides tested cause 40% d
axis).permeate membranes. As each of the lanthanide ions had the abil-
ity to resist peptide-induced permeation, it would be intuitive to
use the lanthanide with the greatest mass adsorption. It should
be noted that Ab42 may bind to varying degrees to the other lan-
thanide ions but as a proof of concept that lanthanide ions resist
Ab association to the membranes we dedicated this study to a sin-
gle lanthanide ion to fully study the lanthanide-Ab molecular
mechanism.
The addition of 10 lM Ctx to 0–500 lM Eu3+ resulted in concen-
tration dependent saturation of the membrane surface (Supple-
mentary Fig. 3). Increasing the coordination of Eu3+ above 10 lM
resulted in a very slight increase in Ctx adsorption to the mem-
brane surface compared to membranes coordinated with 10 lM
Eu3+. This could be an effect of oversaturation of the membrane
surface that results from a kind of steric hindrance between the
metal ions overcrowding the GM1 receptors.
3.3. Eu3+ complexed to LUVs in solution inhibits oligomeric Ab42
induced permeation
We have previously shown that lipid bilayers containing GM1
are highly susceptible to permeation by oligomeric Ab42 [27]. A
calcein release assay was employed to observe Ab-induced perme-
ation of LUVs in solution of a simple membrane composition. The
addition of oligomeric Ab42 alone resulted in an immediate release
of 37% of the total encapsulated calcein from the LUVs (Table 1),
indicative of Ab-induced membrane permeation (Fig. 2) and in
agreement with previous results [27]. Next, LUVs were preincu-
bated with Eu3+ and this was followed by the addition of oligo-
meric Ab42. Eu3+-complexed membranes resulted in the release
of only 0.7% of the total encapsulated calcein (Fig. 2 and Table 1).
Therefore, incubation of the Ab42 with the Eu3+-coordinated LUVs
showed a 56-fold decrease in membrane permeation relative to
LUVs incubated in the absence of Eu3+ (Fig. 2).
Fibrillar Ab42 has previously been shown to cause less perme-
ation to membranes than oligomeric Ab42 [27]. The addition of fib-
rillar Ab led to 3% of the total encapsulated calcein release from
LUVs in the absence of Eu3+ (Table 1), significantly less than perme-
ation induced by oligomeric Ab42. The addition of fibrillar Ab42 to
Eu3+-complexed LUVs resulted in the release of 0.7% of the totalf BODIPY release. Comparison of the mass of various lanthanide metal ions adsorbed
al ions compared to the other lanthanide ions tested (primary y-axis). Addition of
ecrease in permeation compared to when lanthanides are not present (secondary y-
Table 1
Percentage of total calcein released from encapsulated membranes showing the effect
of europium complexation on Ab42-induced membrane permeation. Comparison of
the membrane permeation effects of Ab42 as a result of Eu3+ complexation to the
GM1-containing membranes. Eu3+ causes a significant inhibitory effect toward both
oligomeric and fibrillar Ab42-induced membrane permeation (± are the standard
error of the mean.
LUV administered samples % Total calcein release
0 h (oligomers) Ab42 + Eu3+ 0.67% ± 0.16
24 h (fibrils) Ab42 + Eu3+ 0.70% ± 0.18
0 h (oligomers) Ab42 37.23% ± 4.26
24 h (fibrils) Ab42 3.00% ± 2.94
Fig. 3. SPR measurement of 10 and 100 lM europium adsorption to GM1-
containing LUVs. The addition of 10 and 100 lM europium III chloride to tethered
GM1-containing LUVs resulted in a relatively high affinity interaction between the
GM1 and the metal ion.
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to a 4-fold decrease in permeation. These results demonstrate that
Eu3+ protects the membranes from permeation by both oligomeric
and fibrillar Ab42.
3.4. High affinity complexation between Eu3+ and GM1-containing
membranes
In order to investigate the membrane protective mechanism of
Eu3+ against Ab, Surface Plasmon resonance was used to follow
binding of Ab42 to tethered LUVs in the presence and absence of
Eu3+. Initially, the affinity of the Eu3+ with GM1 containing mem-
branes was considered. Two concentrations of Eu3+ (10 or
100 lM) were injected into the flow-cell, and incubated with the
GM1-containing LUVs until equilibrium was reached. The adsorp-
tion of 10 and 100 lM Eu3+ resulted in a 0.39 and 1.46 up-shift
in angle-resolved resonance minima, respectively. This change in
the resonance minima equates to the adsorption of 2.09 ng mm2
(±0.69) of 10 lM and 7.82 ng mm2 (±0.59) of 100 lM Eu3+, calcu-
lated using the equation (A) = Dh/(Dh/r). Adsorption of 10 lM Eu3+
to the tethered LUVs resulted in an equilibrium dissociation con-
stant of KD = 0.48 lM (±0.04) and the adsorption of 100 lM Eu3+
resulted in a KD = 0.63 lM (±0.18) (Fig. 3), which represents strong
binding of a similar strength to the specific binding between cho-
lera toxin and GM1 [26].
3.5. Eu3+-complexed to LUVs inhibits the interaction of oligomeric
Ab42 to the membrane surface
Surface Plasmon field-enhanced Fluorescence Spectroscopy
(SPFS) was used to concurrently measure Ab adsorption to theFig. 2. Calcein release assay monitoring the permeation of 0-h (oligomer) and 24-h
(fibrillar) incubated Ab42 permeation of LUVs. 10 lM 0 h- or 24 h-incubated Ab42
was added to 100 lM Eu3+-coordinated LUVs and to LUVs alone. Calcein fluores-
cence was monitored for 60 min until equilibrium was reached. Addition of Ab42 to
Eu3+-complexed LUVs show decreased permeation of membranes in solution. Data
was normalized and plotted as percentage released.membrane surface, the avidity of these interactions and the fluo-
rescence flux through the permeated membranes [15,26].
10 lM oligomeric Ab42 was injected into the flow-cell and the
change in mass monitored. 10 lM Eu3+ significantly reduced Ab42
adsorption to the tethered LUVs, while 100 lM Eu3+ almost
entirely prevented the adsorption of Ab42 (Fig. 4). The Eu3+ and
Ab42 mass binding and equilibrium dissociation constants are
shown in Table 2. The adsorption of 10 lM Eu3+ resulted in a 6%
decrease in the binding between Ab42 and the LUVs, whereas the
addition of 100 lM Eu3+ resulted in a 94% decrease in binding
between Ab42 and the LUVs. The peptide was non-specifically
adsorbed to the membrane surface and was easily washed off into
solution. Thus, the addition of 100 lM Eu3+ to LUVs inhibited the
ability of Ab42 to bind to membranes in a concentration dependent
manner.
The association binding data (kon) were further analyzed by fit-
ting to mathematical exponential curve model to determine the
number of analyte-ligand binding events that occur during the
binding of Ab to the LUV surface, and these values are summarized
in Table 3. The exponential fitting function provides a means to
statistically and mathematically determine the best fit for the
binding between Ab and the membranes, and provides a more
sophisticated fitting procedure that can distinguish curves that
do not follow the simple bimolecular binding. A monophasic
response (single exponential curve function) indicates that a singleFig. 4. SPR measurement of oligomeric Ab42 adsorption to 0, 10, and 100 lM
europium-coordinated LUVs. The addition of oligomeric Ab42 (10 lM) to Eu3+-
complexed tethered LUVs and the binding of the peptide to the membrane surface
was monitored. Increasing concentrations of Eu3+ resulted in significant decrease in
Ab42 binding. The exponential phases for each europium concentration associated
with the determined biphasic exponential functions are included and reported in
Table 3.
Table 2
Comparison of europium and Ab42 binding and permeation constants. Comparison of
the mass of Eu3+ adsorption to LUVs and subsequent equilibrium dissociation
constants (KD), mass adsorption of Ab42 and apparent dye diffusion coefficient (D⁄) of
oligomeric Ab42 with 0, 10 and 100 lM Eu3+ coordinated GM1-containing LUVs (± are
the standard error of the mean).
Eu3+
conc.
(lM)
Eu3+
binding
(ng mm2)
Eu3+ KD
(lM)
Ab42
binding
(ng mm2)
D⁄ (m2 s1)
0 – – 2.68 ± 0.54 1.72  1015 ± 1.5  1015
10 2.09 ± 0.69 0.48 ± 0.04 2.51 ± 0.38 2.18  1016 ± 1.2  1016
100 7.82 ± 0.59 0.63 ± 0.18 0.16 ± 0.11 3.92  1017 ± 2.69  1017
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occurring, such as the binding of single Ab molecule to one GM1
receptor. A biphasic response (2 exponential curves) indicates
two distinct and different binding events occurring during the
association of Ab to the membrane surface, for example, the speci-
fic association of the Ab peptide to the GM1 receptor followed by
GM1 induced seeding fibrillization of Ab on the membrane surface,
as has previously been reported [18].
From the model fitting and the analysis of the Ab42 oligomer-
membrane binding in the absence of europium (0 lM Eu3+), it
was revealed that there were two distinct binding events between
Ab42 and the membranes (show as t1 and t2 in Table 3), because
the best curve fit was found to be to two consecutive exponential
curves. Phase (I) the initial 1:1 specific binding between Ab42 to
the GM1-containing membranes (t1). This is then followed by
Phase (II), non-specific binding of Ab42 to the membranes and/or
Ab elongation as a result of GM1-induced seeded fibrillization
(Fig. 4). Because the binding is relatively strong, a non-specific
adsorption of Ab to the LUVs is unlikely. Self-assembly and fibril-
lization of Ab42 on the membrane surface would be more in line
with the observed binding, and we hypothesize that the specific
Ab-bound GM1 is acting as a seed for further Ab molecules to
aggregate. The first event occurs between 11 and 430 min (Phase
I, t1), and corresponds to the immediate binding of the Ab to the
GM1-containing membrane surface (Fig. 4 and Table 3). The sec-
ond exponential curve fits from the beginning of 430 min (Phase
II, t2), which corresponds to the GM1-Ab complex acting as a seed
for further Ab fibrillization (Fig. 4 and Table 3).
The binding of oligomeric Ab42 to 10 lM Eu3+ complexed-LUVs
revealed that the best fit was also obtained using the biphasic
exponential function, therefore, two binding events are occurring
similar to when no europium is present. The first binding phaseTable 3
Exponential function fitting for Ab42 oligomer to the Eu3+-coordinated LUVs.
Exponential functional expression and statistical analysis to determine mono- and
bi-phasic association of the oligomeric Ab with Eu3+-coordinated membranes. a0 and
a1 = mono- and bi-phasic exponent per-factors respectively, the larger the per-factor
signifies a larger contribution to that particular phase in the binding process. t1 and
t2 = characteristic time constants for mono- and bi-phasic exponential fit (min)
respectively, showing the time scale each time phase occurs. Monophasic fit columns
do not have values for a1 and t2 because these are the per-factor and time constant
values that only contribute to the second exponent calculated for the biphasic fits.
Cor. co = correlation coefficient. RMS = root mean square.
Exponential
parameter
0 lM Eu3+ 10 lM Eu3+ 100 lM Eu3+
Mono-
phasic
Bi-
phasic
Mono-
phasic
Bi-
phasic
Mono-
phasic
Bi-
phasic
a0 95.11 10.7 35.1 4.4 4.9  105 8.7  103
a1 – 93.2 – 33.2 – 1.3  105
t1 (min) 286.8 11 375 60 2.0  107 9.0  105
t2 (min) – 430 – 505 – 9.9  105
Chi Sq 6773.6 356.0 472.7 83.0 85.3 85.4
Cor. co 0.99 1.0 1.0 1.0 1.0 1.0
RMS% error 0.08 0.02 0.02 0.01 0.06 0.06occurs between 60 and 505 min (t1 Table 3), corresponding to
the initial binding of Ab to the membrane surface (Fig. 4), but took
significantly longer to occur compared to when europium was
absent (81% increase in the initial t1 time phase) (Table 3). This
is attributed to the low concentration of europium blocking a sig-
nificant proportion of the GM1 binding sites and also altering the
net charge of the membrane surface, therefore, the Ab took longer
to bind to the membranes because of the alteration in membrane
surface elicited by the low concentration of europium. The second
phase occurs at 505 min corresponded to the beginning of the Ab
fibrillization resulting from the GM1-seeding effect (Fig. 4 and
Table 3).
Analysis of Ab42 association to 100 lM europium coordinated
membranes showed a poor fit to a mono-, bi- and tri-phasic expo-
nential fitting and were therefore all excluded. This showed that
Ab42 did not bind significantly to 100 lM Eu3+ coordinated LUVs,
suggesting that the Ab binds non-specifically to membranes coor-
dinated with high concentrations of Eu3+, as all the GM1 binding
sites are occupied by the metal ions and there is a significant alter-
nation in membrane charge caused by the positive metal ions that
results in electrostatic repulsion between the Ab and the mem-
brane surface. The exponential model fitting calculations shows
that increasing Eu3+ concentrations significantly affected the bind-
ing of Ab42 to membrane surfaces, and that Eu3+ caused an
increase in the time taken for Ab42 to initially associate with LUVs.
10 lM Eu3+ caused a 5.4 fold delay in the initial association and
formation of defects in the membrane compared to when Eu3+
was absent (Table 3, t1 and t2).
3.6. Eu3+-complexed to LUVs inhibits oligomeric Ab42-induced
permeation of LUVs
The addition of oligomeric Ab42 to Eu3+ complexed LUVs
resulted in decreased rates of BODIPY fluorophore diffusion
(Fig. 5). A simple theoretical model was previously developed to
fit the decrease in fluorescencetime curves (apparent dye diffu-
sion coefficient (D⁄)), and detailed in Ref. [26]. The addition of
Ab42 oligomers to LUVs resulted in D⁄ = 1.72  1015 m2 s1
(±1.5  1015). In contrast, when Ab42 oligomers were added to
10 lM Eu3+-complexed LUVs, the D⁄ fell to D⁄ = 2.18  1016 m2 -
s1 (±1.2  1016). Therefore, 10 lM Eu3+ coordinated LUVs
resulted in an 87% decrease in membrane permeation rate.Fig. 5. SPFS measurement of oligomeric Ab42-induced permeation of 0, 10, and
100 lM europium-coordinated LUVs. Dye diffusion of the BODIPY induced by the
addition of oligomeric Ab42 (10 lM) to Eu3+-complexed tethered LUVs and the
permeation of the membranes was monitored by SPFS as changes in fluorescence.
Increasing concentrations of europium resulted in significant decrease in Ab42-
induced permeation. Included are the exponential phases for each europium
concentration associated with the determined biphasic exponential functions
reported in Table 2.
Fig. 6. Schematic diagram of the proposed mechanism of europium inhibition of Ab binding to membranes. The administration of europium blocks Ab42 from interacting
with the GM1-containing membranes, and inhibition of subsequent membrane permeation. Europium is proposed to selectively form cooperative complexes with the
oligosaccharide and sialic acid residues via the europiummetal center via electrostatic and hydrogen bonds that results in a coordination shell. The schematic is adapted from
[19] and is not to scale.
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(±2.69  1017), showing an 82% decrease in permeation compared
to in the absence of Eu3+ and a 98% decrease compared to 10 lM
Eu3+ coordinated LUVs (Table 2).
Interestingly, although the 10 lM Eu3+ did not appear to have a
strong effect on binding of Ab42 to tethered LUVs, this lower Eu3+
concentration still had a strong effect on the peptide binding lag-
phase and peptide assembly on the membrane (Table 3). There
was a significant effect of Eu3+ on resulting BODIPY diffusion rates,
which may indicate a link between self-assembly of Ab42 on the
membrane and the mechanism of Ab42-induced membrane per-
meation. We posit that as Ab42 begins to self-assemble into higher
order oligomers (phase II Figs. 4 and 5), diffusion of the fluorophore
is reaching equilibrium and permeation is completed.
4. Discussion
The interactions between Ab42 and membranes have been
hypothesized to play an important role in the mechanism of cyto-toxicity in AD. Our previous work showed that soluble oligomeric
Ab42 binds to GM1-containing membranes and causes the perme-
ation of phospholipid membranes [15,27]. Here, we demonstrate
that (i) Eu3+ shows the greatest mass adsorption to GM1 containing
membranes compared to the other lanthanide ions tested, and all
the ions tested share similar abilities to resist Ctx-induced perme-
ation in control studies; (ii) the interaction between Ab42 and
membranes is inhibited by the formation of complexes formed
between Eu3+ and GM1 gangliosides; (iii) Calcein-encapsulated
LUVs incubated with Eu3+ prevented the permeation of the mem-
branes caused by Ab42; (iv) Ab42 showed decreased binding to
Eu3+ preincubated membranes, consequently inhibiting Ab42
membrane-induced permeation; We are also able to correlate the
events that coincide between Ab binding, permeation of the mem-
branes and disturbance of biomimetic membrane homeostasis.
This is highly significant as these events have not been previously
measured simultaneously and directly linked, giving us a clearer
picture of the molecular events associated with the binding and
permeation of membranes by Ab.
Fig. 7. Schematic of the phases that occur during Ab42-induced membrane permeation. (a and b) Ab42 in close proximity to the GM1-containing membrane surface becomes
associated with the GM1 gangliosides with high affinity (as determined by SPR Fig. 4). (c) Ab42 begins to permeate the first lipid bilayer within 30 s of contact with the
membrane (as determined by AFM in Ref. [15]). (d) Ab42 permeated through both leaflets of the membrane bilayer and allows non-specific diffusion between the internal
space into the extracellular environment (as demonstrated by SPFS Fig. 5). (e) Ab assembly and fibrillization occurs, whereby Ab42-bound GM1 acts as a seed for further Ab42
assembly and the formation of higher order oligomers and fibers. (a–d) Represents the specific interactions of Ab to the membrane surface and initial permeation events as
demonstrated in Phase I (Figs. 4 and 5). (e) Represents the initiation of Ab42 assembly/fibrillization and fluorophore diffusion equilibrium events as demonstrated in Phase II
(Figs. 4 and 5). The addition of Eu3+ results in the blocking of the GM1 gangliosides, therefore inhibiting both Phases I and II by blocking the specific Ab–membrane
interactions and altering the membrane surface properties.
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LUVs reveals that Eu3+-complexed LUVs resist Ab42-induced per-
meation by reducing the binding of Ab42. Our results highlight
the significant role for GM1 and membrane properties in the mech-
anisms of Ab toxicity. Arising from the findings reported here, a
schematic of a proposed mechanism of Eu3+ inhibition of Ab42-
membrane interactions is shown in Fig. 6. GM1 has been shown
to play a pivotal role in Ab42-membrane interactions and Ab42-
induced permeation. The polar moiety of the GM1 provides a com-
plementary surface for the polar amino acids to allow the forma-
tion of hydrogen bonds. GM1 gangliosides also provide a site of
Ab attachment to membranes [36–39], and Ab has been shown to
colocalize in GM1-rich lipid raft microdomains [39]. Eu3+ was pre-
viously shown to covalently interact with the oligosaccharide and
sialic acid moiety of the GM1 [19]. Therefore, if Eu3+ is blocking the
GM1 site, it is no longer available to participate in Ab interactions,
aid Ab polymerization that may lead to permeation of membranes.
These results underline the importance of the Ab toxic mechanism
being mediated by GM1.
The decrease in permeation upon the addition of Ab42 to
Eu3+-coordinated membranes may be attributed to the change
in the membrane charge resulting from the coordination of the
positive trivalent Eu3+ ions to the membrane surface. Increasing
the attractive electrostatic interactions between Ab and GM1
results in increased insertion pressure due to the Ab penetration
into the membrane surface [40]. The solvent exposed aromatic
residues of Ab are able to stack onto the sugar rings of the
GM1 driven by the net positive charge of the GM1 sugar rings
that are in close proximity to the p-electron cloud of the amino
acid aromatic ring [41]. Here, the positively charged Eu3+ ions
would cause electrostatic repulsion toward the highly solvent
exposed arginine residue 5 of Ab42, which lies next to the
aromatic phenylalanine at position 4 that can form stacking
interactions with the GM1 sugar rings. By changing the net
charge of the membrane with the coordination of positively
charged Eu3+, the N-terminus of Ab42 is repelled from the mem-
brane surface. It has been demonstrated that dipolar compounds
that shield the membranes negative charge can prevent the asso-
ciation of Ab peptides with membranes and decrease Ab-induced
cell toxicity [42], similar to the mechanism we propose here to
occur with Eu3+.The mechanism by which Ab causes membrane damage has
been proposed to occur via three potential mechanisms; pore-
formation, detergent-like and carpeting [43]. SPFS measures
changes in mass in real-time, therefore, any subtle changes are
monitored and visualized simultaneously. If the addition of
oligomer Ab42 resulted in total or partial lysis or removal of
the lipid bilayer by a detergent-like mechanism, this would be
observed as a decrease in the SPR signal. However, this is not
observed (Fig. 4), therefore, a detergent-like mechanism of mem-
brane permeation is not supported by our data. We have previ-
ously shown that Ab42 rapidly forms defects and holes in planar
phospholipid bilayers [15]. In support of this, here we demon-
strate that the Phase I of Ab42 binding to the membranes
continues for 400 min. This establishes that, even though the ini-
tial formation of defects occurs very quickly, Ab continues to
bind to the membranes for a much longer time causing the
formation of stable defects within the membrane. Phase II of
binding and fluorophore diffusion that we attribute to Ab self-
assembly and fibrillization, would therefore not heavily influence
the formation of membrane defects and permeation processes
because they have already occurred much earlier during Phase
I. This may suggest that mechanistically, the initial binding of
Ab and the primary formation of membrane defects are the crit-
ical determinant in Ab-induced permeation of the membranes,
and that Ab self-assembly and fibrillization that occur during
phase II are of less importance. We hypothesize that the initial
binding of Ab and formation of defects that correspond to Phase
I (Fig. 4) is the time period where the most significant damaging
events occur. These initial defects during Phase I are significant
enough to cause dramatic membrane damage. We attribute
Phase II (Fig. 4) to Ab self-assembly and fibrillization, and during
this time period, membrane homeostasis has already been signif-
icantly disrupted. A schematic of these events is shown in Fig. 7.
Therefore, prevention of the interaction of Ab with membranes
could be an important factor in preventing and reducing Ab
membrane damage.
Here we show that lanthanide ions, and in particular Eu3+ rep-
resents a potential Ab–membrane interaction inhibitor that could
provide a novel strategy of altering the course of Ab42 assembly
and aggregation on the membranes and may effectively reduce
the cytotoxicity associated with Ab42.
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